US Patent 8501440 Fibrillation-resistant insulin and insulin analogues
Patent 8501440 was granted and assigned to Case Western Reserve University on August, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08501440 Fibrillation-resistant insulin and insulin analogues US Patent 8501440 Fibrillation-resistant insulin and insulin analogues
Infobox
Patent Number
085014400
Patent Number
85014400
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
085014400
Date of Patent
August 6, 2013
0Patent Application Number
134728330
Date Filed
May 16, 2012
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08501440 Fibrillation-resistant insulin and insulin analogues
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08501440
Date of patent
August 6, 2013
Patent application number
13472833
Date Filed
May 16, 2012
Patent primary examiner
Find more entities like US Patent 8501440 Fibrillation-resistant insulin and insulin analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
